Patents by Inventor JING-WEI XIONG

JING-WEI XIONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Compositions for Treating Vascular Disease
    Publication number: 20100047246
    Abstract: This invention relates to compositions and methods for use in treating or preventing vascular disease, as well as diseases and conditions associated with hematopoiesis and cellular proliferation.
    Type: Application
    Filed: July 17, 2007
    Publication date: February 25, 2010
    Applicant: The General Hospital Corporation
    Inventors: Jing-Wei Xiong, Mark C. Fishman
  • Vascular endothelial zinc finger 1 gene and protein and uses thereof
    Publication number: 20030167479
    Abstract: The present invention relates to the diagnosis and treatment of vascular disorders, and to assays for the identification of agents which act upon the circulatory system. It is based, at least in part, on the identification of a novel mouse gene, termed Vezf1 (for “Vascular endothelial zinc finger 1”), which is expressed at higher levels during embryonic development of the circulatory system, in damaged blood vessels, and in newly formed blood vessels associated with tumor growth.
    Type: Application
    Filed: January 17, 2002
    Publication date: September 4, 2003
    Applicant: Mount Sinai School of Medicine of the City University of New York
    Inventors: Heidi Stuhlmann, Jing-Wei Xiong, Mark B. Taubman
  • Vascular endothelial zinc finger 1 gene and protein and uses thereof
    Publication number: 20020023277
    Abstract: The present invention relates to the diagnosis and treatment of vascular disorders, and to assays for the identification of agents which act upon the circulatory system. It is based, at least in part, on the identification of a novel mouse gene, termed Vezf1 (for “Vascular endothelial zinc finger 1”), which is expressed at higher levels during embryonic development of the circulatory system, in damaged blood vessels, and in newly formed blood vessels associated with tumor growth.
    Type: Application
    Filed: May 22, 1998
    Publication date: February 21, 2002
    Inventors: HEIDI STUHLMANN, JING-WEI XIONG, MARK B. TAUBMAN